Abstract
The role of Cardiovascular diseases, in mortality statistics has long been firmly established. However, after improvement of treatment for essential hypertension the mortality due to cardiac & renal failure has decreased which were once the major causes for death due to hypertension. Although the principal causes of mortality are cerebral & myocardial infarction due to associated atherosclerosis (1). Epidemiological studies show essential hypertension is most commonly prevalent among the age group of 40–60 yrs in both sexes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Davidson, S. and Macleod, J. The Principles and practice of medicine, Churchill Livingstone, 1973.
Hathcock, J.N. Ed. Nutritional Toxicology Vol. 1 Academic Press, New York, London 1982.
Iyenger G.V. Science Today, Feb. 32, 35, 1985.
Perry, H.M. Jr. and Schroeder, H.A. J. Lab. Clin. Med. 46: 636–640, 1955.
Schoeder, B.A. J. Chronic Dis. 18: 647–556, 1965.
Carroll, R.E. J. Am. Med. Assoc. 198: 267–269, 1965.
Perry, H.M. Jr. and Erlanger, M.W., Am. J. Physiol. 220: 808–811, 1971.
Perry, H.M. Jr., and Erlanger, M.W. and J. Lab. Clin. Med. 82: 808–811, 1971.
Perry, H.M. Jr., Erlanger, M.W. and Perry, E.F. Am. J. Physiol. 232: 114–121, 1977.
Perry, H.M. Jr., Erlanger, M.W. and Perry, E.F. Environ. Health Perspect. 28: 251–260, 1979.
Thind, G.S. and Fischer, G.M. Exe. Mol. Pathol. 22: 326–334, 1975.
Schroeder, H.A. and Vinton, W.H. Am. J. Physiol. 202: 515–518, 1962.
Schroeder, H.A., Nason, A.P. and Mitchener, M. Am. J. Physiol. 214: 796–800. 1968.
Talwar, S., Qadry, J.S., Pillai, K.K. and Arora, R.B. Ind. J. Pharmacol. 17 Suppl. 1: Abs. No. 084, 1985.
Talwar S., Qadry, J.S., Pillai, K.K. and Arora R.B. 4th int. Cong. Orient. Med. Tokyo, Japan, Oct. 1985.
Revis, N.W., Major, T.C., Horton, C.Y., J. Am. Coll. Toxicol. 2(2): 165, 1983.
Roonwal, G.S., Bhatia, B., Khan, S.U. and Arora, R.B. (1985): Ind. J. Pharmacol. 17 Suppl. 1:111, 1985.
Thind, G.S. and Fisher G.M. Clinical Science and Molecular Medicine, 51: 483–486, 1975.
Quetsch, R.M., Achor, R.W.P., Litin, E.M. and Faucett, R.L. Circulation, 19: 366–375, 1959.
Nayler, W. J. Pharmac. Exp. Ther. 139: 222–229, 1962.
Emas, S., and Fyro, B. Acta Physiol Scand, 63: 358–369, 1965.
Gaunt, R., Chart, J.J. and Renzi, A.A.A.A. Rev Pharmac. 2: 109–128, 1963.
Goodwin, F.K., Ebert, M.H. and Bunney, W.E. Jr. R. - Shader, Raven Press, New York pp. 25–47, 1972.
Nadkarni, A.K. Indian materia medica, Bombay popular Prakashna, 1, 1976.
Khan, S.U., Kheterapal, K., Khanna, T., Zahid, M. and Arora, R.B. (Abstract). Accepted for second International Conference on elements in health and disease-1987.
Department of health. Education and Welfare, Food and Drug Administration U.S. Federal Register, Aug. 8, 1978 Part IV, 35186–35208.
Hundnick V., Gomiseek M.M. and Gomiseek S. Anal. Chim. Acta, 157: 143–150, 1984.
Hundnick V., Gomiseek M.M. & Gomiseek S. Anal. Chim, Acta, 157: 303–311, 1984.
Khan, S.U., Roy S. and Arora, R.B. In “Development of Unani drugs from herbal sources and the role of elements in their mechanism of action” Ed. R.B. Arora Hamdard National Foundation monograph, IHMMR, printing press, New Delhi, 1985.
Iyengar, G.V., In: Development of Unani drugs from herbal sources and the role of elements in their mechanism of action. (Ed. Arora R.B.) Hamdard National Foundation, Monograph, 1985. pp. 21–44.
Schroeder, H.A. and Ballasa, J.J. Am. J. Physiol. 209: 62–66, 1964.
Schroeder, H.A. and Buckman. Arch. Environ. Health 14: 693–697, 1967.
Schroeder, H.A., Circulation 35: 570–82, 1967.
Schroeder H.A. North Am. 58: 381–396, 1974.
Perry, H.M. Jr. Erlanger M.W. and Perry, E.F. 8th Annual Conference on Trace substances in 1974, Environmental Health. Univ. of Missouri, pp. 51–57.
Frazeir, J.M. Fundam, Appl. Toxicol. 1(6): 452–456, 1981.
Petering, H.G., Johnson, M.A. and Stemmer, K.L. (Abst) Proc. Fed. A. Soc. Exp. Biol. 28: 9–61, 1969.
Petering, H.G., Johnson, M.A. and Stemmer, K.L. Arch. Environ. Health 23: 93–101, 1971.
Verma M.P., Sharma, R.P. and Bourcier, P.R. Biol. Trace Hem, Res. 4: 35–43, 1982.
Lanwerys, R. In: “The chemistry. Biochemistry and Biology of Cadmium.” pp. 433–455, Webb, Med., Elservier.
Friberg, L., Piscator, M., Nordberg, G.F. and Kjellstrom, T. Second Ed. Chemical Rubber Co. Press, Cleveland 1974.
Murata, I., Hirono, T.O., Saeki, Y. and Nakagawa, S. Bull. Soc. Int. Chir. 1:34. 1970.
Baader, E.W. Dtsch. Med. Wochenschr. 76: 487–494, 1951.
Hunter, Dr. Arh. Hig. Rada, 5: 221–224, 1954.
Friberg, L. Acta Med. Scand. 218 (Suppl.): 240, 1950.
Friberg, L., Proc. 9th Int. Congr. Ind. Med. pp. 641–44, 1948.
Perry, H.M. Jr. and Schroeder, H.A. J. Lab. clin. Med. 46: 936, 1955.
Roonwal, G.S., Bhatia, B., Khan, S.U. and Arora R.B. Asian Congress of Pharmacology, New Delhi, 1985.
Arora, R.B., Roy, S. and Khan, S.U., Acta Pharmacologica et. Toxicologica 58(Suppl 11): 1986 In Print.
Doyle, J.J., Bernhoft, R.A. and Sandstead, H.H. J. Lab. Clin. Med. 86: 57–63, 1975.
Lener, J. and Musit, J. Experentia. 29: 902, 1971.
Perry, H.M. Jr., Erlanger, M.W., Yunice, A. and Perry, E.F.J. Lab. Clin. Med. 70: 963–72, 1967
Perry, H.M. Jr. and Erlanger, M.W. J. Lab. Clin. Med. 82: 339–405, 1973.
Perry, H.M. Jr. and Erlanger, M.W. Cadmium as both an antinaturetic and pressure agent. In “ace substance in Environ Health” XIV ed. Hemphill. D.D. University of Missouri, 280–286, 1980.
Revis, N.W., Zinsmeister and Bull, R. Proc. natl. Acad. Sci. USA 78: 6494–6498, 1981.
Prasad, R., Sharma, N., Paliwal, V.K., Annrel, I.S. and Nath, R. Proc. Nat. conf. on lead, zinc and cadmium at work place: Environment and Health care. New Delhi 2: 1–16, 1982.
Lyall, V., Mahmood, A. and Nath, R. Ind. Jour. Biochem Biophys. 16: 80–83, 1979.
Prasad, R., Paliwal, V.K., Sharma, N. and Nath, R. (abstract) Toxicology Letters, 18: 8, 1983.
Cain, K. and Holt, D.G. Chem. Biol. Interact, 28: 91–106, 1979.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Arora, R.B., Bhatia, B., Khan, S.U., Roy, S., Ansari, N.I., Tamanna, S.A. (1987). Ajmaloon a Unique Herbal Polypharmaceutical Possessing Both Hypotensive and Cadmium Lowering Property. In: Beamish, R.E., Panagia, V., Dhalla, N.S. (eds) Pharmacological Aspects of Heart Disease. Developments in Cardiovascular Medicine, vol 68. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2057-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2057-9_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9222-7
Online ISBN: 978-1-4613-2057-9
eBook Packages: Springer Book Archive